Literature DB >> 27584967

Pathophysiology and Treatment of Hyperhidrosis.

Tomoko Fujimoto1.   

Abstract

Primary focal hyperhidrosis is a disease of unknown cause with profuse perspiration of local sites (head, face, palms, soles of feet, and axillae) that adversely affects daily life. Guidelines have been proposed in the USA [<citeref rid="ref1">1</citeref>], Canada [<citeref rid="ref2">2</citeref>], and Japan [<citeref rid="ref3">3</citeref>]. The symptoms impair quality of life, with significant negative effects on daily existence and personal relationships. The current goal in medical practice for patients with hyperhidrosis is to provide guidance and encourage coping skills for a normal daily life, as well as give appropriate advice regarding treatment options. On occasion, in order to improve quality of life, it is necessary to recommend surgical therapy when conservative treatment fails; this requires an understanding of the mechanisms of available treatments and their effects. This paper reviews theories of primary focal hyperhidrosis with regard to pathology, epidemiology, and treatment.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27584967     DOI: 10.1159/000446786

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  4 in total

1.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 2.  The Etiology of Primary Hyperhidrosis: A Systematic Review.

Authors:  Moshe Hashmonai; Alan E P Cameron; Cliff P Connery; Noel Perin; Peter B Licht
Journal:  Clin Auton Res       Date:  2017-08-19       Impact factor: 4.435

Review 3.  Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art.

Authors:  Miłosz Lewandowski; Zuzanna Świerczewska; Wioletta Barańska-Rybak
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

4.  Treatment of Palmar Hyperhidrosis with Tap Water Iontophoresis: A Randomized, Sham-Controlled, Single-Blind, and Parallel-Designed Clinical Trial.

Authors:  Do Hun Kim; Tae Han Kim; Seung Ho Lee; Ai Young Lee
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.